Loading...
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors
The use of activated factor VII (FVIIa) for the treatment of bleeding events in haemophilia patients with inhibitors was first reported over 30 years ago. Since then clinical trials, registries, case series, real‐world experience and an understanding of its mechanism of action have transformed what...
Na minha lista:
| Udgivet i: | Haemophilia |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899648/ https://ncbi.nlm.nih.gov/pubmed/31489759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13845 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|